Saito, M., Kaibara, A., Kadokura, T., Toyoshima, J., Yoshida, S., Kazuta, K., & Ueyama, E. (2020). Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus. Diabetes Ther.

Saito, Masako, Atsunori Kaibara, Takeshi Kadokura, Junko Toyoshima, Satoshi Yoshida, Kenichi Kazuta, e Eiji Ueyama. "Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients With Type 2 Diabetes Mellitus." Diabetes Ther 2020.

Saito, Masako, et al. "Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients With Type 2 Diabetes Mellitus." Diabetes Ther 2020.